Joint Disease Clinical Trial
Official title:
Efficacy and Safety of Intra-articular Multiple Doses of 500 µg Icatibant Including 40 mg Triamcinolone as Calibrator in a Randomized, Double-blind, Parallel-group, Placebo-controlled 13-week Multi-centre Study in Patients With Symptomatic Knee Osteoarthritis
The primary objective is to compare the overall treatment effect on pain relief between icatibant and placebo. The secondary objectives are to assess the efficacy of icatibant in term of onset, extent and duration of pain relief relative to triamcinolone, to evaluate the safety of icatibant, to evaluate overall conditions of daily life after treatment with icatibant, to assess systemic exposure of icatibant following intra-articular injection.
This is a multinational, randomized, placebo-controlled study to be conducted in Europe and the US. Study medication will be administered by intra-articular injection 3 times in weekly intervals, being followed by an observation period of further 11 weeks. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02314702 -
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems
|
||
Completed |
NCT03271151 -
Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT03272139 -
Interscalene Block Versus Superior Trunk Block
|
Phase 4 | |
Completed |
NCT01407874 -
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
|
Phase 2 | |
Completed |
NCT01256216 -
Signature Versus Computer Assisted Surgery Study
|
N/A | |
Completed |
NCT03337243 -
Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis
|
N/A | |
Active, not recruiting |
NCT03294408 -
Multimodal Imaging of Subchondral Bone in Knee Osteoarthritis : Predictive Model
|
N/A | |
Withdrawn |
NCT02668211 -
Radiostereometric Analysis (RSA) of the PROFEMUR® Preserve Classic Femoral Components
|
N/A | |
Active, not recruiting |
NCT02239783 -
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® TL Modular Femoral Stems
|
||
Terminated |
NCT00698347 -
A Clinical Investigation of the M2a-Magnumâ„¢ Hip System
|
N/A | |
Completed |
NCT00223353 -
Quantitative Gait Analysis for Clinical Decision Making
|
N/A | |
Recruiting |
NCT04037735 -
RSA-RCT: Attune S+ TKA Versus Sigma TKA
|
N/A | |
Terminated |
NCT03575975 -
3D X-ray Motion Analysis of Ankle-foot Motion After Total Ankle Arthroplasty
|
||
Completed |
NCT03894514 -
Multi-variable Prediction Model of Total Knee Replacement Outcome
|
||
Completed |
NCT02865447 -
Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis
|
||
Enrolling by invitation |
NCT03576573 -
Post Market Clinical Follow-Up Study Protocol for PROCOTYL® C Acetabular Components
|
||
Completed |
NCT02967874 -
Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment
|
Phase 1/Phase 2 | |
Completed |
NCT02390336 -
Mobilization With Movement in Patients With Osteoarthritis of the Hip
|
N/A | |
Terminated |
NCT03293719 -
Post-market Follow up Study of the 'BPK-S Integration' UC as Primary Implant in the Variants CoCr or Ceramic
|
||
Active, not recruiting |
NCT02823834 -
PMCF Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components
|